- What is Medasense Biometrics' primary focus?
- Medasense Biometrics specializes in noninvasive pain-monitoring solutions, providing technology that helps clinicians optimize and personalize pain control while avoiding overmedication.
- What is Medasense Biometrics' flagship product?
- Medasense Biometrics' flagship product is the PMD-200, which uses its NOL index, artificial intelligence, and a proprietary noninvasive sensor platform to objectively monitor and quantify a patient's pain response.
- Where is the PMD-200 used?
- The PMD-200 is used to optimize pain management in operating rooms and critical care settings, particularly for patients who are unable to communicate their pain.
- Which company distributes the PMD-200 in Europe?
- Medtronic exclusively distributes Medasense Biometrics' PMD-200 in Europe.
- In which regions is the PMD-200 cleared for marketing?
- The PMD-200 is cleared for marketing in Canada, Latin America, Israel, and Australia.
- What is the total funding raised by Medasense Biometrics?
- Medasense Biometrics has raised a total of $33.5 million USD.
- When did Medasense Biometrics receive its most recent funding?
- Medasense Biometrics received funding in January 2025 from the BIRD Foundation.
- Which investors participated in Medasense Biometrics' September 2020 funding round?
- Sabadell Asabys VC and OTV participated in Medasense Biometrics' funding round in September 2020.
- How many employees does Medasense Biometrics have?
- Medasense Biometrics has 11-50 employees.
